Cutia Therapeutics
HKEX:2487
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Cutia Therapeutics
HKEX:2487
|
CN |
|
Toppan Inc
OTC:TOPPY
|
JP |
|
LG Energy Solution Ltd
KRX:373220
|
KR |
|
One REIT Inc
TSE:3290
|
JP |
|
R
|
Refrigeration Electrical Engineering Corp
VN:REE
|
VN |
|
S
|
Sleep Country Canada Holdings Inc
OTC:SCCAF
|
CA |
|
Nomura Real Estate Holdings Inc
OTC:NMEHF
|
JP |
|
A
|
Abionyx Pharma SA
LSE:0RAG
|
FR |
|
United Labels AG
F:ULC
|
DE |
Wall St Price Targets
Price Targets Summary
Cutia Therapeutics
According to Wall Street analysts, the average 1-year price target for Cutia Therapeutics is 11.45 HKD with a low forecast of 7.52 HKD and a high forecast of 15.75 HKD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Cutia Therapeutics's stock price target?
Price Target
11.45
HKD
According to Wall Street analysts, the average 1-year price target for Cutia Therapeutics is 11.45 HKD with a low forecast of 7.52 HKD and a high forecast of 15.75 HKD.
What is the Revenue forecast for Cutia Therapeutics?
Projected CAGR
38%
Over the last 3 years, the compound annual growth rate for Revenue has been 209%. The projected CAGR for the next 7 years is 38%.
What is the Gross Profit forecast for Cutia Therapeutics?
Projected CAGR
-39%
Over the last 3 years, the compound annual growth rate for Gross Profit has been 191%. The projected CAGR for the next 2 years is -39%.
